ScreenerHero

CURXCuranex Pharmaceuticals Inc Common Stock

NAS · US · Healthcare · Biotechnology · curanexpharma.com
4.710USD+1641.86%Mkt Cap: 7.39M $P/E: —

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap7.39M $
Enterprise Value162.63M $
Revenue (TTM)—
Gross Profit-7.84M $
Net Income (TTM)-4.23M $
Revenue/Share—
Last Price4.710 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B405.38
EPS (TTM)-7.19
EPS (Forward)—
52W Range
0.178850% of range9.180
52W High9.180 USD
52W Low0.1788 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-37.66%
ROA-36.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.48M $
CapEx (TTM)—
FCF Margin—
FCF Yield-104.57%
Net Debt-2.66M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio45.95
Quick Ratio28.17
Book Value/Sh0.0130 USD
Cash/Share0.0940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateAug 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.57M
Float10.11M
Insiders61.35%
Institutions1.07%
Short Interest
Short Ratio0.2d
Short % Float0.14%
Short % Out.0.04%
Shares Short619
Short (prev mo.)1.04K
Technical
SMA 504.677 (+0.7%)
SMA 2007.010 (-32.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)149.45K
Avg Vol (10d)26.11K
Technical Indicators
RSI (14)65.8
MACD0.8149
MACD Signal0.3216
MACD Hist.+0.4932
BB Upper4.278 USD
BB Middle0.8969 USD
BB Lower-2.4847 USD
BB Width754.08%
ATR (14)0.9440 USD
Vol Ratio (20d)0.15x